Nano Plasma Membrane Vesicle‐Lipid Nanoparticle Hybrids for Enhanced Gene Delivery and Expression
Advanced Healthcare Materials · 2025-01 · 14 (1)
DOI: 10.1002/adhm.202401888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.11.2024. Verfasst von Claudio Luca Alter und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, Basel, 4056, Switzerland. Hauptthemen laut MEDLINE: Nanoparticles, Zebrafish, Gene Transfer Techniques, Lipids. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Swiss Nanoscience Institute, Phospholipid Research Center.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) have emerged as the leading nonviral nucleic acid (NA) delivery system, gaining widespread attention for their use in COVID‐19 vaccines. They are recognized for their efficient NA encapsulation, modifiability, and scalable production. However, LNPs face efficacy and potency limitations due to suboptimal intracellular processing, with endosomal escape efficiencies (ESE) below 2.5%. Additionally, up to 70% of NPs undergo recycling and exocytosis after cellular uptake. In contrast, cell‐derived vesicles offer biocompatibility and high‐delivery efficacy but are challenging to load with exogenous NAs and to manufacture at large‐scale. To leverage the strengths of both systems, a hybrid system is designed by combining cell‐derived vesicles, such as nano plasma membrane vesicles (nPMVs), with LNPs through microfluidic mixing and subsequent dialysis. These hybrids demonstrate up to tenfold increase in ESE and an 18‐fold rise in reporter gene expression in vitro and in vivo in zebrafish larvae (ZFL) and mice, compared to traditional LNPs. These improvements are linked to their unique physico‐chemical properties, composition, and morphology. By incorporating cell‐derived vesicles, this strategy streamlines the development process, significantly enhancing the efficacy and potency of gene delivery systems without the need for extensive screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, Basel, 4056, Switzerland.
- Swiss Nanoscience Institute, University of Basel, Klingelbergstrasse 82, Basel, 4056, Switzerland.
- Biozentrum, University of Basel, Spitalstrasse 41, Basel, 4056, Switzerland.
- Novartis BioMedical Research, 100 Technology Square, Cambridge, MA, 02139, USA.
- Novartis Biologics Research Center, Fabrikstrasse 16, Basel, 4056, Switzerland.
- Department of Chemistry, University of Basel, Mattenstrasse 24a, BPR 1096, Basel, 4058, Switzerland.
ORCID-Profile: Claudio Luca Alter, Claudia Lotter, Jaroslaw Sedzicki, Valentin Schittny, Pascal Detampel, Jörg Huwyler
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Swiss Nanoscience Institute
- Phospholipid Research Center
- Swiss Centre for Applied Human Toxicology
Zitieren
APA
Alter, C. L., Lotter, C., Puligilla, R. D., Bolten, J. S., Sedzicki, J., Marchese, J., Schittny, V., Rucci, F., Beverly, M., Palivan, C. G., Detampel, P., Einfalt, T., & Huwyler, J. (2025). Nano Plasma Membrane Vesicle‐Lipid Nanoparticle Hybrids for Enhanced Gene Delivery and Expression. Advanced Healthcare Materials, 14(1). https://doi.org/10.1002/adhm.202401888
Vancouver
Alter CL, Lotter C, Puligilla RD, Bolten JS, Sedzicki J, Marchese J, et al. Nano Plasma Membrane Vesicle‐Lipid Nanoparticle Hybrids for Enhanced Gene Delivery and Expression. Advanced Healthcare Materials. 2025;14(1). doi:10.1002/adhm.202401888
BibTeX
@article{Alter2025,
author = {Alter, Claudio Luca and Lotter, Claudia and Puligilla, Ramya Deepthi and Bolten, Jan Stephan and Sedzicki, Jaroslaw and Marchese, Jason and Schittny, Valentin and Rucci, Francesca and Beverly, Michael and Palivan, Cornelia G and Detampel, Pascal and Einfalt, Tomaž and Huwyler, Jörg},
title = {Nano Plasma Membrane Vesicle‐Lipid Nanoparticle Hybrids for Enhanced Gene Delivery and Expression},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {1},
doi = {10.1002/adhm.202401888}
}
EUVIMED